Broad scales up as Biogen scales back in Kendall Square - The Boston Globe
Biogen teams up with Ginkgo Bioworks in gene therapy manufacturing pact - MedCity News
Home | Biogen
Company | Biogen
Biogen - Биоген - Photos | Facebook
Biogen and Alcyone Therapeutics partner up for novel device for neurological ASO therapies
Biogen Foundation | Biogen
Home | Biogen
Drug companies are making an accounting change after the SEC cracked down on Biogen - MarketWatch
Biogen Stock Flies On Upgrade; Why Alzheimer's Is A $7 Billion Opportunity | Investor's Business Daily
Biogen Seeks to Sublease Cambridge, Weston Properties - Banker & Tradesman
Home | Biogen
Code of Business Conduct | Biogen
Biogen Plunges After Making Changes to Alzheimer's Drug Trial | BioSpace
Biogen Stock: How Biogen Makes Money In 2022 And How They Defied Gravity
Biogen-C | Rachael Rosewood Skin Clinic
Biogen shakes up R&D role, splitting it into two
Biogen shares soar after patent victory | Financial Times
Biogen Recoups Much-Needed $2.3B with Sale of Samsung Bioepis Stake | BioSpace
Biogen makes another Alzheimer's bet, paying Pfizer $75M for early-phase drug | Fierce Biotech
UPDATE: Sandrock makes a sharp exit, retiring as Biogen R&D chief amid fallout from Aduhelm approval | Fierce Biotech
Biogen, at a Crossroads, Surges on Promising Alzheimer's Drug Assessment - WSJ
Biogen - Биоген - Biogen - Биоген updated their cover photo.
Biogen bags Karyopharm neurological drug in $217M deal | Fierce Biotech
Medicare recipients foot bill for a rejected Alzheimer's drug - Marketplace
